Embryonic stem cells (ESCs) are regulated by pluripotency-related transcription factors in concert with chromatin regulators. To identify additional stem cell regulators, we screened a library of endogenously labeled fluorescent fusion proteins in mouse ESCs for fluorescence loss during differentiation. We identified SET, which displayed a rapid isoform shift during early differentiation from the predominant isoform in ESCs, SETa, to the primary isoform in differentiated cells, SETb, through alternative promoters. SETa is selectively bound and regulated by pluripotency factors. SET depletion causes proliferation slowdown and perturbed neuronal differentiation in vitro and developmental arrest in vivo, and photobleaching methods demonstrate SET's role in maintaining a dynamic chromatin state in ESCs. This work identifies an important regulator of pluripotency and early differentiation, which is controlled by alternative promoter usage.
INTRODUCTION
Embryonic stem cells (ESCs), derived from the inner cell mass of preimplantation embryo, have the capability to give rise to all cell types of an adult organism (Evans and Kaufman, 1981) . Although considerable attention has been devoted to the biology of ESCs, we are still far from understanding the complete underlying molecular mechanisms that govern pluripotency and lineage flexibility. To date, a core set of transcription factors (TFs) in concert with chromatin regulators has been identified, maintaining the ''stem cell state'' (Chambers and Tomlinson, 2009; Lessard and Crabtree, 2010; Loh et al., 2011) .
Chromatin has been at the focal point in stem cell biology due to a variety of roles it plays in conferring and maintaining pluripotency (Fazzio et al., 2008; GasparMaia et al., 2009; Lessard and Crabtree, 2010) . Extensive modifications and rearrangements both at the global and local levels take place in chromatin structure during differentiation of ESCs Yamazaki et al., 2007) , from a more dynamic, permissive structure in the pluripotent state to a restricted conformation following differentiation (Efroni et al., 2008) . Some of the factors responsible for this hyperdynamic plasticity have recently begun to emerge, and include histone acetylation and methylation (Melcer et al., 2012) , several histone modifiers and chromatin remodeling proteins (Cervoni et al., 2002; Gaspar-Maia et al., 2009; Ho et al., 2009) , as well as the nuclear lamina protein Lamin A (Melcer et al., 2012) . Despite this extensive research, additional regulators of pluripotency are still being identified (Betschinger et al., 2013; Cheloufi et al., 2015; Ho et al., 2015; Respuela et al., 2016) , and it is clear that additional factors await discovery.
To identify additional stem cell regulators, we generated a library of endogenously labeled fluorescent fusion proteins in R1 mouse ESCs (Harikumar et al., 2017 [this issue of Stem Cell Reports] ). Here, we report that SET nuclear oncogene (SET, also known as TAF-I), a multifunctional linker histone chaperone, undergoes an isoform switch during early ESC differentiation via alternative promoters, and is involved in regulating pluripotency, proliferation, and differentiation of mouse ESCs.
RESULTS

Screening for Downregulated Proteins during ESC Differentiation
To identify potential regulators of pluripotency and ESC differentiation, we screened for proteins that are downregulated early upon retinoic acid (RA)-induced differentiation. Fluorescence levels, representing endogenous protein levels, were monitored using live time-lapse microscopy over 4 days. Using this screen, we identified SET nuclear oncogene (SET), which was rapidly downregulated after the induction of differentiation ( Figures 1A-1C and Movie S1). As expected from previous reports (Kato et al., 2011) , SET was mainly found in the nucleus (Figures 1A and S1A-S1C). Interestingly, SET protein levels appear to reflect the differentiation state of ESCs in culture, with undifferentiated colonies showing high fluorescence and early differentiating colonies or colony edges showing reduced fluorescence ( Figure S1B ). These results suggest that SET is predominantly expressed in ESCs (Figures S1B-S1D) and is reduced during ESC differentiation, and that our N-terminal YFP tag of SET ( Figure 1B ) did not alter its nuclear localization.
Alternative Promoters Give Rise to Two Different SET Isoforms
The Set gene is located on chromosomes 2 and 9 in mouse and human, respectively. The Set gene is alternatively spliced, with four transcripts predicted to give rise to protein products of varying sizes ( Figure S1E ). SET is well conserved across species, with mouse and human SET proteins sharing 94% similarity. SET has two prominent isoforms, SETa and SETb (Matsumoto et al., 1993; Nagata et al., 1995) (Figures 1E-1G and S1E-S1H). SET isoforms share most of the coding sequence except the first exons ( Figure 1B ), thus giving rise to almost identical proteins, which differ only at their N terminus ( Figure 1D ). SETa has a 36-amino-acid (aa) a-specific region and SETb has a 24-aa b-specific region (Nagata et al., 1995) . A dimerization domain and a highly acidic C-terminal domain, which is important for binding acetylated proteins such as p53 (Wang et al., 2016) , follow these unique N-terminal isoform-specific regions ( Figure 1D ). SETb is the most widely expressed isoform in differentiated cells, whereas SETa is expressed in a limited number of differentiated cell types and is usually expressed at considerably lower to non-existent levels compared with the b isoform (Nagata et al., 1998) . In our YFP-SET clone, the YFP was integrated in intron 1, after the SETa-specific 5 0 exon ( Figure 1B) , and therefore only SETa, and not SETb, is tagged by YFP, conveniently allowing us to distinguish between the two isoforms. To measure the levels of the SETa-and SETb-specific isoforms in ESCs, we performed qPCR analysis using primers specific to the unique 5 0 exons. The expression level of SETa was considerably higher than that of SETb in ESCs both at RNA and protein level (Figures S1H and 1G) . Interestingly, SETa mRNA decreased rapidly during differentiation with a gradual concomitant rise in SETb levels ( Figures 1E and 1F ), demonstrating an isoform switch at the transcriptional level. Western blots using anti-SET antibodies that recognize both isoforms show that the SETa decreased rapidly and SETb levels increased moderately during differentiation ( Figure 1G ). Finally, RNA sequencing (RNA-seq) tracks from ESCs and mouse embryonic fibroblasts (MEFs) from different sources (Shen et al., 2012; Yue et al., 2014) provided further support for the SETa/SETb isoform switch between ESCs and MEFs at the RNA level ( Figure 1H ). Since we readily detected both YFP-tagged SET and native SET in the YFP-SET clone (Figure S1F) , we conclude that SET expression is biallelic.
Core Pluripotency Factors Bind and Regulate SETa Expression
The unique elevated levels of SETa in ESCs and its abrupt decrease during differentiation called for testing its expression regulation. To this end, we used publicly available datasets (Chen et al., 2008; Marson et al., 2008) of epigenetic modifications and TF binding maps, as well as the BindDB webtool, recently developed by our group (Aaronson et al., 2016; Livyatan et al., 2015) , enabling in silico reverse-chromatin immunoprecipitation (ChIP) analysis, to search for potential emerging features of the SET promoter(s). Our in silico analysis revealed that the upstream regions of both SETa and SETb 5 0 exons are enriched for H3K4me3 ( Figure S2A , bottom), a mark of active transcription. This nicely depicts the existence and location of the alternative SET promoters. As expected from an active gene, we did not find any enrichment for H3K27me3 in these promoter regions ( Figure S2A ). Analyzing the binding of TFs to SET promoters, we found that at least nine TFs, many of which are ESC specific, bind the SETa, but not the SETb, promoter ( Figure 2A ). BindDB analysis revealed that none of the pluripotency factors bind the SETb promoter, which was instead bound by factors such as TOPOIIa, TET1, OGT, HDAC2, FBXL10, CAPG, and CTR9, suggesting a more poised state ( Figure 2A ). The binding of SETa promoter by OCT4, SOX2, KLF4, and NANOG was confirmed by ChIP-qPCR ( Figure 2B ). These data suggest that the two isoforms are distinctly regulated and that the SETa promoter alone is bound by the pluripotency network TFs.
OCT4 Regulates SETa Expression in ESCs
Next, we wished to test the functional significance of the binding of the pluripotency factors to the SETa promoter.
To determine the effect of OCT4 on SETa expression, we took advantage of the Zhbtc4 ESC system, in which endogenous Oct4 gene is under the control of doxycycline (Dox) (Niwa et al., 2000) . Addition of Dox completely abolishes OCT4 expression ( Figures 2C and 2F ). While OCT4-depleted cells began to differentiate after 48 hr, 24 hr after Dox addition the Zhbtc4 ESC colonies remained undifferentiated and appeared similar to the control colonies in morphology ( Figure S2B ) and Nanog expression ( Figure 2C ). Importantly, SETa, but not SETb, was selectively decreased (by $50%) in the Dox-treated cells after 24 hr ( Figures 2D and 2E ), suggesting that SETa, but not SETb, is controlled by OCT4. These results were confirmed at the protein level ( Figure 2F ), although due to the higher stability of the protein the effect is more subtle. Next, we examined the previously published RNA polymerase II (RNAPII) occupancy data in the Zhbtc4 cells after OCT4 depletion (Rahl et al., 2010) , and found a selective decrease at the SETa promoter 24 hr after Dox addition ( Figure 2G ).
Figure 2. SETa Expression Is Regulated by Pluripotency Factors in ESCs (A)
In silico reverse-ChIP analysis for SET. For every query, our BindDB webtool and pipeline returns the TFs and chromatin modifications that are enriched at the promoter region (proximal or distal). Dark green, binding; light green, no binding. Green, blue, and red boxes depict TFs or histone marks associated with active chromatin, pluripotency, or poised chromatin, respectively. (B) ChIP analysis of pluripotency factors at the SETa promoter (left). SETa gene body corresponding to a region in intron 7 was used as a negative control (right) (data are shown as mean ± SD; n = 3 independent experiments). (C) qRT-PCR analysis of Oct4 and Nanog mRNA levels in Zhbtc4 cells before and after Dox treatment. Expression levels were normalized to GAPDH (data are shown as mean ± SD; n = 3 independent experiments). (D and E) qRT-PCR analysis of SETa (D) and SETb (E) mRNA levels in Zhbtc4 cells before and after Dox treatment. Expression levels were normalized to GAPDH expression (data are shown as mean ± SD; n = 3 independent experiments). (F) Western blots of SETa, SETb, and OCT4 in Zhbtc4 cells before and after Dox treatment. GAPDH was used as a loading control. (G) Binding profiles of RNAPII at SETa and SETb promoters before (0 hr) and after (24 hr) Dox addition. Data are from Rahl et al. (2010) .
Taken together, these data demonstrate a highly selective promoter-specific regulation of SETa, but not SETb, by OCT4 and likely other pluripotency factors ( Figure S2C ).
SET Regulates Cell Proliferation and Survival of ESCs
To explore the role of SET in ESCs, we generated stable knockdown (KD) clones of total SET, and used the CRISPR/Cas9 system to selectively disrupt either SETa, SETb, or both (SET-DKO) in mouse ESCs (Figures S3A-S3C, 3A, and 3B). All KD and knockout (KO) clones were verified by qPCR and western blotting, and KO clones were further validated by sequencing. Interestingly, SETa KO ESCs showed increased levels of SETb transcripts (Figure S3C ). The SET-DKO clones grew slowly and formed small colonies. We therefore reverted to analyzing the stable SET-KD clones, where most, but not all, of the protein is depleted ( Figures 3A and 3B ). The morphology of the SET-KD clones remained unaltered when grown on MEFs ( Figure S3D ), as well as the expression level of OCT4, NANOG, and KLF4 ( Figures S3E and 3C ). However, there was a slight increase in the expression level of differentiation markers of all three germ lineages ( Figure S3F ). (E) Reduced proliferation in SET-KD ESCs (*p < 0.05, 2-tailed t test). Cell number of SET-depleted ESCs was normalized to Scr-ctrl cell number. Error bars represent ±SD (n = 3 independent biological experiments). (F) Cell-cycle analysis of SET-KD cells. Cell number in each phase was normalized to that of Scr-ctrl (n = 3 independent experiments; error bars represent ±SD; *p < 0.05, 2-tailed t test). (G) KH2-ESC proliferation assay following overexpression (OE) of SETa or SETb (n = 3 independent experiments; error bars represent ±SD). (H) Representative images of clone formation assay of control (top), SETa-OE (bottom left), and SETb-OE (bottom right) wells. Colonies were detected with AP staining (pink). (I) Quantification of (H) (n = 3 independent experiments; error bars represent ±SD; *p < 0.05, 2-tailed t test).
Expression microarrays confirmed a relatively minor effect on gene expression with 67 and 120 genes reproducibly upregulated and downregulated (1.5-fold cutoff), respectively, in the undifferentiated SET-KD clones (Figures 3D and S3G-H; Table S1 ). A closer look at the downregulated genes revealed a class of genes that are specifically involved in the G 2 /M phase of the cell cycle, of which Cdc16 and Anapc4 govern the exit from mitosis. To test the role of SET on cell-cycle kinetics, we performed proliferation assays in SET-KD and SET-overexpressing (OE) cells. After 96 hr, we observed a $40% decrease in cell numbers in the SET-KD clones compared with controls ( Figure 3E ), without any apparent influence on cell death. Fluorescence-activated cell sorting-based cell-cycle analysis using propidium iodide revealed a shift from S to G 2 /M phase in the SET-KD population ( Figure 3F ), suggesting that SET depletion slows down cells in the G 2 /M phase. To test the effects of SET overexpression on proliferation, we used KH2 ESCs (Supplemental Experimental Procedures) to individually overexpress either YFP-SETa, hemagglutinin (HA)-SETa, or HA-SETb in ESCs ( Figures S3I-S3K ). We found that SET overexpression increased ESC proliferation rates by $1.4-fold ( Figure 3G ).
We next tested the effect of the SET isoforms on imparting survival advantage to ESCs. We performed a clone-formation assay of SETa-or SETb-OE KH2 cells with and without Dox, and stained the cells for alkaline phosphatase (AP) 6 days later. SETa and SETb overexpression increased colony numbers by $2.3-fold and $1.7-fold, respectively ( Figures 3H and 3I ), indicating that SET can impart survival advantage, consistent with its effect on proliferation. The fact that both SETa and SETb had similar effects suggests that the N-terminal region of SET is not involved in these processes. These results are also in line with observations in cancer cell lines, where SET isoforms are greatly overexpressed, increasing the cancer cells' survival rate and proliferative capacity (Carlson et al., 1998; Fukukawa et al., 2000) .
SET Regulates Neuroectodermal Differentiation of ESCs
To investigate the effect of SET-KD on ESC differentiation, we induced control (Scr-ctrl) and SET-KD cells to differentiate with RA ( Figure 4A ). By day 4, while Scr-ctrl cells differentiated normally into NESTIN-positive cells as expected ( Figure 4B, top) , the SET-KD clones formed Nestin-negative circular colonies of small round cells, surrounded by NESTIN-positive cells ( Figure 4B, bottom) . The cells within the circular colonies were negative for the pluripotency marker OCT4 (Figure 4C ), suggesting that they did not remain undifferentiated. Testing different lineage markers we found that the OCT4-negative circular colonies expressed the early endodermal marker GATA4 ( Figure 4D ). The Scr-ctrl cells were all negative for GATA4, as expected (O) IF for TUJ1 (red) in differentiated neurons derived from Scr-ctrl (top) and SET-KD ESCs (middle and bottom). Nuclei were counterstained with DAPI (blue). Scale bar, 100 mm. (P) Quantification of neuronal differentiation capacity in Scr-ctrl and KD clones (n = 3 independent experiments; error bars represent ±SD; *p < 0.05, 2-tailed Student's t test).
( Figure 4D, top) . To rule out the possibility that the formation of the circular colonies was due to the more slowly differentiating SET-KD ESCs, we maintained these cultures in RA-containing differentiation medium for 8 days. The cells did not show any progression in differentiation and slowly died (data not shown). These data indicate that the SET-KD clones are defective in ectodermal differentiation. To rule out the possibility that the expression changes we observed were due to different readout of cells at different stages of differentiation, we performed a timecourse differentiation experiment. The SET-KD cells were differentiated for 6 days and the expression of pluripotency and neuronal differentiation markers was quantified by qPCR. Here also we observed a similar general trend in marker expression in the KD clones, i.e., increased pluripotency factor expression ( Figure 4E ) and increased endodermal gene expression ( Figure 4F , bottom). These results suggest that the effects of SET on differentiation are not due to different readouts of cells at different stages.
We next used non-directed differentiation into embryoid bodies (EBs). By day 5, the SET-KD EBs gave rise to small fluid-filled EBs, gradually growing into large EBs by day 8 ( Figure 4G ). Interestingly, many of the fluid filled EBs formed from the SET-KD clones gave rise to spontaneously beating cellular aggregates in suspension (Movie S2), suggesting cardiomyocyte differentiation. Control EBs appeared normal and did not produce any beating EBs. Overexpression of either SETa or SETb did not alter EB formation and differentiation ( Figure 4H ), suggesting that SET is important, but not limiting, during this process.
Since RA differentiation of SET-KD cells yielded considerably fewer NESTIN-positive cells, we further tested the potential of the SET-KD cells to generate neuronal progenitor cells (NPCs) (Lee et al., 2000) . The SET-KD cells gave rise to a significantly lower number of NPCs (by >50%, p < 0.05) compared with controls ( Figures 4I and 4J ). To rule out unspecific clonal or knockdown artifacts, we stably reintroduced SETa or SETb or a control pN1 vector into the SET-KD clones ( Figure 4K ) and repeated the neuronal differentiation. All clones formed normal EBs, but when differentiated into NPCs, SETa addback only partially rescued the differentiation phenotype ($45%) ( Figures 4L and 4M) , while SETb addback gave rise to fibroblast-like cells which, curiously, stained positive for NESTIN ($40%). We also observed, once again, increased tendency to spontaneously form beating foci only in the SET-KD clones ( Figure 4N ). As expected, pN1 addback was similar to that of SET-KD clones, failing to generate NPCs ($10%), while the Scrctrl differentiated normally. These data indicate that SET plays an important function in neurogenesis.
We also tested whether the few emerging SET-KD NPCs could give rise to mature neurons (Efroni et al., 2008; Lee et al., 2000) . The Scr-ctrl NPCs differentiated into Tuj1-positive neurons efficiently and formed networks ( Figure 4O , top). In contrast, SET-KD NPCs formed very few Tuj1-positive neurons and grew into fibroblast-like cells (Figures 4O  and 4P) . Unexpectedly, the SET-KD clones gave rise to a large number of single beating cells of varying shapes and sizes (Movie S3). These findings once again indicate that SET depletion propels ESCs toward an endodermal lineage in the expense of neuroectoderm.
To gain molecular insight, we performed gene expression microarray analyses of RA-induced (4 days) SET-KD clones versus Scr-ctrl. RA-induced SET-KD cells had 178 upregulated and 419 downregulated genes compared with controls (Figures 3D and S4A ; Tables S2 and S3 ). Interestingly, some of the upregulated genes are involved in the maintenance of pluripotency ( Figure S4A ). Changes in selected genes were reconfirmed by qRT-PCR ( Figure S4B ). Additional prominent examples of altered genes include several Hox cluster genes (Hoxb13, Hoxd1, Hoxd4, Hoxd8, and Hoxd13), which failed to be induced during differentiation. Hoxd4, Hoxd8, and Hoxd13 were all shown to play important roles during neuronal differentiation (Zha et al., 2012) , possibly explaining the aberrant neuronal induction phenotypes described above. In addition, SET-KD cells failed to upregulate many genes involved in neurogenesis (Table S4) confirmed by gene ontology analysis (Figure S4C ). This suggests that SET acts as an upstream activator of a battery of transcription factors that are required for neuronal differentiation. We cannot exclude the possibility that SET is acting on a few neuronal master regulators but in either case, SET, and particularly SETb, appears to control neuronal gene expression during differentiation.
We next set out to test the effects of SETa on directed differentiation to NPCs. For this we used the KH2 system, which allowed us to knock in, using the FLPe recombinase, SETa or SETb under a Dox-controlled promoter (Beard et al., 2006) . First, we assessed the effect of SET isoform overexpression on pluripotency marker levels in self-renewing ESCs. qPCR analysis revealed no apparent effect on pluripotency marker expression on SET-OE isoforms for 2 days ( Figure S4D ). We next sought to understand the effect of SET overexpression on ESC differentiation. Individual SET isoforms were overexpressed in ESCs differentiated into EBs for 4 days. We found that while SETb overexpression had no discernible effect, SETa isoform overexpression suppressed mesodermal (Brachyury) and endodermal (Gata4) marker expression ( Figure 5A ), consistent with the SET-depletion experiments, where endodermal lineage markers were upregulated in the SETdepleted cells ( Figure S3F ). To test the effects of SETa OE on neuronal differentiation, we used both KH2 cells and KH2-HA-SETa cells, differentiated in either the continued presence of 0.5 mg/mL Dox, constantly driving SETa overexpression, or with transient Dox (1 mg/mL) induction for Figure 5 . SETa Is Essential for Maintaining the ESC State (A) qRT-PCR analysis of the lineage-specific factors Nestin (blue), Brachyury (red), and Gata4 (green) in SET-control, SETa-OE, and SETb-OE ESCs and in 4-day differentiated EBs (n = 3 independent experiments; error bars represent ±SD; *p < 0.05; 2-tailed t test). Expression levels were normalized to GAPDH. (B) Experimental layout of NPC differentiation from SET-OE ESCs.
(legend continued on next page) 2 days only ( Figure 5B ). Continued SETa expression resulted in fewer and aberrant NPCs ($75% less), while transient SETa expression resulted in normal NESTIN-positive NPCs, similarly to control KH2-ESCs ( Figures 5C-5E ). Moreover, continuous SETb overexpression had no discernible effect on NPC generation. These data show that high levels of SETa are detrimental for early neuronal differentiation, and that SETa levels must decline to ensure proper neurogenesis. Based on all combined data, we propose that SETb is a lineage-choice factor that promotes neurogenesis during early differentiation and that SETa antagonizes this process.
Since SET overexpression had dramatic effects on in vitro differentiation, we next wished to examine the effects of SETa and SETb on differentiation in vivo. We injected SET-KD, SET-OE, and control cells subcutaneously in severe-combined-immunodeficient (SCID) mice. Control ESCs, uninduced KH2-HA-SETa ESCs, uninduced KH2-HA-SETb ESCs, as well as SET-KD cells all formed teratomas, with cells of all three germ layers present, although the SET-KD teratomas appeared smaller. Unexpectedly, when SETa was induced by addition of Dox to the mice's drinking water, no teratomas were produced ( Figure S5A ) and we could not detect any undifferentiated cell mass at the site of injection. This suggests that high levels of SETa expression are incompatible with differentiation both in vitro and in vivo, although only in vitro SETa promoted proliferation. To further test this phenomenon, we injected wild-type, SETa-KO, SETb-KO, and SET-DKO ESCs into SCID mice. Remarkably, while both the SETa-KO and the SET-DKO formed teratomas, albeit the latter's were smaller than controls, the SETb-KO ESCs failed to make teratomas. Since the DKO were able to differentiate in vivo, we attribute the failure of the SETb-KO ESCs to generate teratomas to the elevated levels SETa in these cells ( Figure S3B ). This is in line with our SETa-OE experiment whereby increased levels of SETa resulted in loss of teratoma-forming capacity ( Figure S5A) . Finally, to test whether SET is essential for embryonic development, we co-injected SET guide RNA (gRNA) with Cas9 RNA into fertilized zygotes and found developmental arrest (in $25% of the progeny) at around embryonic day 6.5 ( Figures S5B and S5C) .
SET Maintains H1 Dynamics on Chromatin in ESCs SET has been recently reported to act as a histone H1 chaperone in HeLa cells (Kato et al., 2011) . Since in ESCs, chromatin protein dynamics, including H1, is elevated (Christophorou et al., 2014; Melcer et al., 2012; , it was tempting to speculate that SETa might contribute to this hyperdynamic plasticity. To test this, we performed fluorescence recovery after photobleaching (FRAP) analysis in SET-KD and control cells expressing histone H1e-Cherry as conducted previously (Melcer et al., 2012) , and found that H1 recovery was significantly reduced in the SET-KD cells compared with controls (p < 0.001) (Figures 5F and 5G) . This was mostly due to differences in the bleach depth, which represent the highly mobile fraction of the protein (Nissim-Rafinia and Meshorer, 2011) . Since SETa is the predominant form in undifferentiated ESCs, it is likely responsible for this effect, although SETb is also present at low levels. To unequivocally distinguish between the contribution of the two SET isoforms, we repeated the FRAP experiments in KH2 ESCs expressing SETa or SETb separately, and found significantly elevated H1 dynamics (p < 0.02) when SETa was overexpressed in KH2 cells (Figures 5H and 5I ). SETb showed a similar but statistically insignificant trend. These data demonstrate that SETa is chiefly responsible for histone H1 dynamics in ESCs, but also that both variants possess H1 chaperone activity to some extent. To confirm this, we also tested the effect of SET depletion on histone H1e mobility in differentiated cells (MEFs), and found comparable effects ( Figure S5D ). SETa itself is also highly dynamic in both ESCs and differentiated cells ( Figure S5E ), suggesting weak and transient binding to chromatin. Repeated SET ChIP and SET ChIP-sequencing attempts were unsuccessful with only a small fraction of successfully precipitated DNA, supporting the dynamic nature of SET in ESCs. Taken together, these results suggest that SET is a regulator of linker histone dynamics in both ESCs and differentiated cells, and imply that SETa is more efficient in maintaining a dynamic linker histone state, potentially contributing to the hyperdynamics phenotype observed in ESCs (Melcer et al., 2012; .
DISCUSSION
In this study, using our clone library (Harikumar et al., 2017) we identified SET, a nuclear protein previously not implicated in ESC biology or pluripotency, to play a role in maintaining ESCs as well as in lineage choice decisions during differentiation. Notably, according to the human embryo resource (HumER: https://intranet.cmrb.eu/ Human_embryos/) (Vassena et al., 2011) , SET is one of the predominantly expressed proteins in early human development. Based on computational analysis and conditional OCT4 depletion, we show here that SET isoform expression is regulated by two alternative promoters and that in ESCs, SETa is controlled by multiple TFs, including OCT4. The two SET isoforms differ only in their N-terminal portion, while most of the protein ($90%) is shared. We propose that SETa is expressed in ESCs to allow SET's beneficial effects on proliferation and linker chaperone activities, without interfering with differentiation, while SETb is essential for proper differentiation. Supporting this, we found that co-injections of SET gRNA with Cas9 RNA into fertilized zygotes results in halted development around embryonic day 6.5. Therefore, since SETb 0 s specific roles, such as activation of Hox cluster genes, apoptosis, etc., are not compatible with the undifferentiated ESC state, whereas SETa has a superior linker chaperone activity, and both share similar properties in maintaining proliferation, the switch between SETa and SETb is crucial for proper differentiation. Immunoprecipitation followed by mass spectrometry analysis of SETa and SETb separately revealed that although most associated proteins are shared, each isoform has a handful of specific partners that likely act in concert to confer specificity (Data not shown). Histone chaperones such as SET affect various processes of histone metabolism ranging from synthesis to deposition on chromatin (Avvakumov et al., 2011) , and SET itself has been shown to decondense sperm chromatin (Matsumoto et al., 1999) . It is therefore tempting to speculate that high levels of SET would act in a similar fashion in ESCs, contributing to a decondensed chromatin conformation. Supporting this hypothesis, our FRAP analysis indicates that SET is involved in histone H1 release from chromatin in ESCs. Hyperdynamic association of chromatin proteins is a hallmark of pluripotency , and was found to be controlled by histone acetylation and methylation (Melcer et al., 2012) . In this regard, SET seems to have opposing actions on chromatin plasticity. On the one hand it increases linker histone dynamics, likely reflecting its role as an H1 chaperone (Kato et al., 2011) , on the other hand, SET restricts histone H4 acetylation, likely reflecting its association with the INHAT complex (Seo et al., 2001 ). Increased histone acetylation was shown to enhance chromatin protein dynamics in ESCs (Melcer et al., 2012) . How can these seemingly opposing actions of SET be resolved? One option is that its effect on chromatin protein dynamics is restricted to linker histones and that core histones would not be similarly affected. An additional option is that its function as a linker histone chaperone is more important than its function in restricting histone acetylation. The latter is somewhat more likely since increased histone acetylation in ESCs, although it supports the pluripotent state, has very little effect on gene expression (Boudadi et al., 2013; Hezroni et al., 2011) . Taken together, our results suggest that in addition to the other mechanisms previously described that support a dynamic chromatin state in ESCs (Melcer et al., 2012) , high levels of SETa also act in a similar direction to keep chromatin in its characteristic hyperdynamic ESC state.
In summary, the identification of SET, with its alternative isoforms, as a regulator of proliferation and differentiation in ESCs adds to the list of key factors that aid in maintaining the stem cell state. SET is not a typical TF or chromatin remodeler that directly regulates specific events in stem cells. We envisage that SET acts as a potentiating and balancing factor of several key processes in ESCs, rather than a bona fide TF. We were able to identify different functions of the two SET isoforms in ESCs and during differentiation. Based on its intriguing expression pattern during ESC differentiation, its role in embryonic development should now be explored.
EXPERIMENTAL PROCEDURES
Detailed descriptions are provided in Supplemental Experimental Procedures.
All mice were obtained from the Jackson Laboratory and maintained in the Whitehead Institute animal facility. All experiments were approved by the Committee on Animal Care (CAC) at the Massachusetts Institute of Technology, and animal procedures were performed following the NIH guidelines.
All short hairpin RNAs (shRNAs) were selected from the TRC (The RNAi Consortium, Broad Institute) database. The synthesized shRNA oligos were cloned into the lentiviral vector pLVTHM. For proliferation measurements, ESCs were plated in gelatin-coated (0.2%) 6-well plates at a density of 10 5 per well. Dox was added at a final concentration of 1 mg/mL and medium was replaced daily. For neuronal differentiation, 2 3 10 6 ESCs were seeded on bacterial culture dishes for EB formation. EBs were grown for 4 days in ESC medium with 10% fetal bovine serum without leukemia inhibitory factor (LIF). At day 4, EBs were plated on poly-L-ornithine/fibronectin (PLO/FN)-coated plates for NPC differentiation in DMEM Nutrient Mixture-F12 (HAM) medium containing ITS (insulin/ transferrin/selenium) and FN. NPCs were grown for 3 days in DMEM-F12 ITS/FN medium and fixed with 4% paraformaldehyde. For dopaminergic neuronal differentiation, NPCs were trypsinized and plated on PLO/FN-coated plates. Cells were fed with DMEM-F12 medium containing N2 plus medium/basic fibroblast growth factor/ascorbic acid every day for 4 days. Differentiation of dopaminergic neurons was induced by removing growth factors. Neuronal differentiation was continued for 10 days with continued medium changes every 2 days.
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